Exhibit 99.2

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(Unaudited)

	Three-Month Periods Ended				Nine-Month Periods Ended
	September 30,				September 30,
(in thousands, except per share amounts)	2014		2013		2014		2013
Revenue:
Product revenue	$	6,762	$	5,814	$	22,376	$	14,248
Service and other revenue		2,165		1,607		6,226		4,800
Contractual revenue		11,696		—		15,088		—
Total revenue		20,623		7,421		43,690		19,048
Cost of Revenue:
Cost of product revenue		5,608		4,616		19,048		11,138
Cost of service and other revenue		1,853		1,564		5,678		4,680
Total cost of revenue		7,461		6,180		24,726		15,818
Gross profit		13,162		1,241		18,964		3,230
Operating Expense:
Research and development		11,693		10,419		35,899		34,084
Sales, general and administrative		9,882		10,757		28,025		29,685
Total operating expense		21,575		21,176		63,924		63,769
Operating loss		(8,413)		(19,935)		(44,960)		(60,539)
Interest expense		(716)		(686)		(2,103)		(1,785)
Other income (expense), net		(34)		134		(122)		262
Net loss		(9,163)		(20,487)		(47,185)		(62,062)
Other comprehensive income (loss):
Unrealized gain (loss) on investments		(19)		13		9		(19)
Comprehensive loss	$	(9,182)	$	(20,474)	$	(47,176)	$	(62,081)
Net loss per share:
Basic and diluted net loss per share	$	(0.13)	$	(0.31)	$	(0.68)	$	(1.01)
Shares used in computing basic and diluted net loss per share		70,740		65,523		69,716		61,636